Simon Lord
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in ⓘ
-
- Cancer, Hypoxia, and Metabolism 13
- Cancer Genomics and Diagnostics 5
- Oncology 37
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 8
- Co-authors
- Adrian L. Harris (17 shared papers)Francesca M. Buffa (11 shared papers)Elena Favaro (2 shared papers)John Greene (1 shared paper)Ashvina Segaran (1 shared paper)Simon Wigfield (2 shared papers)Fredrik Karpe (2 shared papers)Ji‐Liang Li (1 shared paper)
- Journals
- British Journal of Cancer (10 papers)Journal of Clinical Oncology (10 papers)Annals of Oncology (9 papers)Cancer Research (8 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Simon Lord
70 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 920
- Oncology 976
- Radiology, Nuclear Medicine and Imaging 546
- Biochemistry 148
- Genetics 143
Countries citing papers authored by Simon Lord
This map shows the geographic impact of Simon Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Lord more than expected).
Fields of papers citing papers by Simon Lord
This network shows the impact of papers produced by Simon Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Lord. The network helps show where Simon Lord may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Lord, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation Hit paper breakdown → | 2014 | 525 |
| 2 | Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study Hit paper breakdown → | 2019 | 400 |
| 3 | 2014 | 241 | |
| 4 | 2022 | 133 | |
| 5 | 2019 | 105 | |
| 6 | Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? Hit paper breakdown → | 2023 | 82 |
| 7 | 2021 | 79 | |
| 8 | 2021 | 67 | |
| 9 | 2011 | 66 | |
| 10 | 2021 | 56 | |
| 11 | 2018 | 53 | |
| 12 | 2023 | 46 | |
| 13 | 2022 | 41 | |
| 14 | 2022 | 31 | |
| 15 | 2017 | 27 | |
| 16 | 2023 | 25 | |
| 17 | 2020 | 25 | |
| 18 | 2016 | 24 | |
| 19 | 2023 | 23 | |
| 20 | 2019 | 17 |
About Simon Lord
Simon Lord is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Library and Information Sciences and Radiology, Nuclear Medicine and Imaging, having authored 74 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (8 papers), Advanced Breast Cancer Therapies (8 papers), Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (6 papers), Cancer Genomics and Diagnostics (5 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Cancer Research (920 citations), Oncology (976 citations), Radiology, Nuclear Medicine and Imaging (546 citations), Biochemistry (148 citations) and Genetics (143 citations). Simon Lord has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Adrian L. Harris, Francesca M. Buffa, Elena Favaro, John Greene, Ashvina Segaran, Simon Wigfield, Fredrik Karpe, Ji‐Liang Li, Michael J.O. Wakelam and Almut Schulze. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.